Email Updates

Search form

You are here

AVAC Advocacy Partners Forum

At AVAC's annual Partners Forum, we share strategies and successes and set priorities for the future.

Each year, AVAC and a wide array of partners and allies gather to discuss the most urgent issues facing HIV prevention advocates. We share updates from country-level campaigns, look ahead to research results that may emerge in the next 12 months and identify priorities to tackle jointly and individually. It is a time to celebrate success and to re-commit to the work that remains to be done. Scroll down to see images, presentations and video from Partners Forum 2014.

Research to Reality

February 11-13, 2014
Meikles Hotel, Harare, Zimbabwe

Forum Objectives

Facilitating connections – Building the movement
Building skills – Strengthening the collective advocacy capacity
Prioritizing actions – Developing actionable plans around key issues outlined in AR2013 and raised by partners

Meeting Materials

Photos from the Partners' Forum

Agenda with Slides

Tuesday, February 11

  • HIV Prevention Advocacy in 2014: The Big Picture [Slides]
  • VMMC, PrEP, Microbicides, Vaccines and More: A “marketplace” tour of HIV prevention research and implementation
  • Advocacy to DELIVER: Prevention is Prevention – The advocacy landscape for today’s strategies
  • How can prevention advocates work within and influence GFATM processes to expand high impact prevention? – Linda Mafu, Global Fund [Slides]
  • Infuencing PEPFAR Country Operating Plans (COPs) – Maureen Milanga, Health GAP [Slides]
  • Beyond the first 5 million: What’s the new advocacy agenda for voluntary medical male circumcision? Angelo Kaggwa, AVAC
  • Viral load testing and viral suppression: Introduction for advocates – Sandra Simons, MSF [Slides]
  • Components you need and traps to avoid for coalition building – Asia Russell, Health GAP

Wednesday, February 12

“Good morning! Here’s what keeps us up at night…” – Partner updates on compelling issues

  • “Research & Reality: How is it that some African countries can research MSM & HIV, while others can't?” – Mannasseh Phiri
  • "From the Lab to the Bedroom" – Rosemary Mburu

Advocacy to DEMONSTRATE: Getting to Implementation—VMMC non-surgical devices and tenofovir-based PrEP rollout – Peter Kilmarx, CDC Zimbabwe [Slides]

Advocacy to DEMONSTRATE: Setting strategy for 2014

Issue Update: Hormonal Contraceptives and HIV Risk – Why this a key issue for prevention advocates

  • Topic Overview: state of the research, current developments – Mike Chirenje, UZ-UCSF [Slides]
  • Civil society engagement: Perspectives and priorities – Promise Mthembu, HRI; Margaret Happy, ICWEA; Teresia Otieno, Gender and Media Initiative

Advocacy to DEVELOP: Progress and setbacks in the search for an AIDS vaccine and cure – Mitchell Warren, AVAC [Slides]

Vaccine and cure advocacy in the context of long—and shifting—timelines: What does it look like? – Leslie Nielsen, IAVI; Paul Semugoma, LGBTI Health in Uganda; Ntando Yola, NACOSA

Advocacy to DEVELOP: “What Women Want” – Opportunities, highlights and challenges in the research of women’s HIV biomedical prevention interventions

Thursday, February 13

“Good morning! Here’s what keeps us up at night…” – Partner updates on compelling issues...

  • “But Why, Why Why – Holistic advocacy” – Alliance Nikuze, Institute of Human Virology of University of Maryland School of Medicine
  • “Let it Lube” – Jim Pickett, IRMA and Project ARM [Slides]
  • Untitled – Rumbidzai Mapfumo, CeSHHAR

Good Participatory Practice: Making stakeholder engagement in the research process meaningful every step of the way – Stacey Hannah, AVAC; Ntando Yola, NACOSA [Slides]

Advocacy for rollout planning: Preparing for upcoming results in women’s HIV prevention research trials

Putting it all together: Prevention IS Prevention Advocacy for 2014 and Beyond...